INS and metabolic syndrome: Indeed, a meta-analysis of randomized controlled trials in metabolic syndrome subjects reinforced the short cycle of FMT efficacy to reduce glucose, insulin, and glycated hemoglobin levels and increase HDL cholesterol vs. a placebo [80].